J&J reaches sweeping talc deal that could end decade of litigation
New York: Johnson & Johnson said Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark deal that could end a contentious legal battle that has...












































